nach oben

Erschienen in:

01.10.2012 | Review Article

Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus

verfasst von: Odirlei André Monticielo, Thaisa de Mattos Teixeira, José Artur Bogo Chies, João Carlos Tavares Brenol, Ricardo Machado Xavier

Erschienen in: Clinical Rheumatology | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

The susceptibility for the development of systemic lupus erythematosus (SLE) is related to environmental, hormonal, genetic, and immunological factors. Numerous genes have been linked to the emergence of SLE, including vitamin D receptor (VDR) gene that synthesizes the receptor of vitamin D. Several polymorphisms have been described since the discovery of this gene, and their effects on VDR activity are still poorly understood. Vitamin D’s biological functions are mediated by VDR. Vitamin D exerts many actions on the immune system, and several studies have suggested its role in the pathogenesis of autoimmune diseases. SLE patients have low blood levels of vitamin D, which raises the possibility of association between the deficiency of this vitamin and the onset of the disease. BsmI and FokI polymorphic variants seem to be related to the onset of the disease in Asian patients. In this article, we review the aspects related to the metabolism and immunoregulatory effects of vitamin D, VDR, and main polymorphisms involving the VDR gene and the relationship between vitamin D levels and its receptor with SLE.

Oliveira NMP, Lemos MC (2010) Papel da vitamina D na susceptibilidade para a Diabetes Mellitus tipo 1. Dissertação de Mestrado Integrado em Medicina Universidade da Beira Interior, Covilha

DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80(6 Suppl):1689S–1696SPubMed

Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281PubMedCrossRef

Premaor MO, Furlanetto TW (2006) Hipovitaminose D em adultos: entendendo melhor a apresentação de uma velha doença. Arquivos Brasileiros de Endocrinologia 50(1):25–37CrossRef

Valdivielso JM, Fernandez E (2006) Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 371(1–2):1–12PubMedCrossRef

Dusso AS, Brown AJ, Vitamin SE (2005) Vitamin D. Am J Physiol Renal Physiol 289(1):F8–F28PubMedCrossRef

Takeyama K, Kitanaka S, Sato T, Kobori M, Yanagisawa J, Kato S (1997) 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science 277(5333):1827–1830PubMedCrossRef

Kamen D, Aranow C (2008) Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 20(5):532–537PubMedCrossRef

Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16(7):713–716PubMedCrossRef

10.

Bandeira F, Griz L, Dreyer P, Eufrazino C, Bandeira C, Freese E (2006) Vitamin D deficiency: a global perspective. Arq Bras Endocrinol Metabol 50(4):640–646PubMedCrossRef

11.

Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81(3):353–373PubMedCrossRef

12.

Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84(1):18–28PubMed

13.

Malabanan A, Veronikis IE, Holick MF (1998) Redefining vitamin D insufficiency. Lancet 351(9105):805–806PubMedCrossRef

14.

Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT et al (1998) Hypovitaminosis D in medical inpatients. N Engl J Med 338(12):777–783PubMedCrossRef

15.

Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96(1):53–58PubMedCrossRef

16.

Cantorna MT, Mahon BD (2004) Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 229(11):1136–1142

17.

Heaney RP, Holick MF (2011) Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 26(3):455–457PubMedCrossRef

18.

Slomski A (2011) IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims. Jama 305(5):453–454, 6PubMedCrossRef

19.

Yamada S, Yamamoto K, Masuno H, Choi M (2001) Three-dimensional structure-function relationship of vitamin D and vitamin D receptor model. Steroids 66(3-5):177–187PubMedCrossRef

20.

Miyamoto K, Kesterson RA, Yamamoto H, Taketani Y, Nishiwaki E, Tatsumi S et al (1997) Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol 11(8):1165–1179PubMedCrossRef

21.

Durrin LK, Haile RW, Ingles SA, Coetzee GA (1999) Vitamin D receptor 3′-untranslated region polymorphisms: lack of effect on mRNA stability. Biochim Biophys Acta 1453(3):311–320PubMedCrossRef

22.

Decker CJ, Parker R (1995) Diversity of cytoplasmic functions for the 3' untranslated region of eukaryotic transcripts. Curr Opin Cell Biol 7(3):386–392PubMedCrossRef

23.

Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338(2):143–156PubMedCrossRef

24.

Morrison NA, Yeoman R, Kelly PJ, Eisman JA (1992) Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci USA 89(15):6665–6669PubMedCrossRef

25.

Faraco JH, Morrison NA, Baker A, Shine J, Frossard PM (1989) ApaI dimorphism at the human vitamin D receptor gene locus. Nucleic Acids Res 17(5):2150PubMedCrossRef

26.

Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV et al (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367(6460):284–287PubMedCrossRef

27.

Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K et al (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12(6):915–921PubMedCrossRef

28.

Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D (1996) The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 11(12):1850–1855PubMedCrossRef

29.

Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H et al (2000) The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 14(3):401–420PubMedCrossRef

30.

Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT et al (2001) Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 177(1–2):145–159PubMedCrossRef

31.

Colin EM, Weel AE, Uitterlinden AG, Buurman CJ, Birkenhager JC, Pols HA et al (2000) Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin Endocrinol (Oxf) 52(2):211–216CrossRef

32.

van Etten E, Verlinden L, Giulietti A, Ramos-Lopez E, Branisteanu DD, Ferreira GB et al (2007) The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol 37(2):395–405PubMedCrossRef

33.

Trinchieri G, Sher A (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7(3):179–190PubMedCrossRef

34.

Ramanathan B, Davis EG, Ross CR, Blecha F (2002) Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes Infect 4(3):361–372PubMedCrossRef

35.

Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J et al (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173(5):2909–2912PubMed

36.

Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR et al (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311(5768):1770–1773PubMedCrossRef

37.

Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66(9):1137–1142PubMedCrossRef

38.

Deluca HF, Cantorna MT (2001) Vitamin D: its role and uses in immunology. Faseb J 15(14):2579–2585PubMedCrossRef

39.

Kamen DL, Tangpricha V (2010) Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med 88(5):441–450PubMedCrossRef

40.

Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R (2001) Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 98(12):6800–6805PubMedCrossRef

41.

Lanzavecchia A, Sallusto F (2001) Regulation of T cell immunity by dendritic cells. Cell 106(3):263–266PubMedCrossRef

42.

O'Regan S, Chesney RW, Hamstra A, Eisman JA, O'Gorman AM, Deluca HF (1979) Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand 68(1):109–111PubMedCrossRef

43.

Muller K, Kriegbaum NJ, Baslund B, Sorensen OH, Thymann M, Bentzen K (1995) Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 14(4):397–400PubMedCrossRef

44.

Becker A, Fischer R, Schneider M (2001) Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus. Z Rheumatol 60(5):352–358PubMedCrossRef

45.

Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS (2006) Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5(2):114–117PubMedCrossRef

46.

Thudi A, Yin S, Wandstrat AE, Li QZ, Olsen NJ (2008) Vitamin D levels and disease status in Texas patients with systemic lupus erythematosus. Am J Med Sci 335(2):99–104PubMedCrossRef

47.

Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C (2008) Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 47(6):920–923CrossRef

48.

Ruiz-Irastorza G, Gordo S, Olivares N, Egurbide MV, Aguirre C (2010) Changes in vitamin D levels in patients with systemic lupus erythematosus: effects on fatigue, disease activity, and damage. Arthritis Care Res (Hoboken) 62(8):1160–1165CrossRef

49.

Wu PW, Rhew EY, Dyer AR, Dunlop DD, Langman CB, Price H et al (2009) 25-Hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum 61(10):1387–1395PubMedCrossRef

50.

Damanhouri LH, Vitamin D (2009) Deficiency in Saudi patients with systemic lupus erythematosus. Saudi Med J 30(10):1291–1295PubMed

51.

Toloza SM, Cole DE, Gladman DD, Ibanez D, Urowitz MB (2010) Vitamin D insufficiency in a large female SLE cohort. Lupus 19(1):13–19PubMedCrossRef

52.

Ben-Zvi I, Aranow C, Mackay M, Stanevsky A, Kamen DL, Marinescu LM et al (2010) The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One 5(2):e9193PubMedCrossRef

53.

Kim HA, Sung JM, Jeon JY, Yoon JM, Suh CH (2010) Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus. Rheumatol Int 31:1189–1194PubMedCrossRef

54.

Amital H, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T et al (2010) Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 69(6):1155–1157PubMedCrossRef

55.

Zheng YJ, Chen S, Li ZQ, Yuan M, Ao W, Bao CD et al (2010) The relationship of vitamin D endocrine system and estrogen receptor expression with bone mineral density in initial systemic lupus erythematosus. Zhonghua Nei Ke Za Zhi 49(4):309–312PubMed

56.

Szodoray P, Tarr T, Bazso A, Poor G, Szegedi G, Kiss E (2010) The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary. Scand J Rheumatol 40:122–126PubMed

57.

Huisman AM, White KP, Algra A, Harth M, Vieth R, Jacobs JW et al (2001) Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 28(11):2535–2539PubMed

58.

Wright TB, Shults J, Leonard MB, Zemel BS, Burnham JM (2009) Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr 155(2):260–265PubMedCrossRef

59.

Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M (2009) Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int 20(3):427–433PubMedCrossRef

60.

Lora P, Scalco R, Furlanetto TW, Xavier RM (2008) Vitamin D status in patients with systemic lupus erythematosus from southern Brazil, vol 46(Supplement: IFCC WorldLab Fortaleza 2008. Clinical Chemistry and Laboratory Medicine, Walter de Gruyter, New York, p 7

61.

Souto M, Coelho A, Guo C, Mendonca L, Argolo S, Papi J et al (2011) Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors, and relationship with activity. Lupus 20(10):1019–1026PubMedCrossRef

62.

Mok CC, Birmingham DJ, Leung HW, Hebert LA, Song H, Rovin BH (2011) Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford) 51(4):644–652CrossRef

63.

Carvalho JF, Blank M, Kiss E, Tarr T, Amital H, Shoenfeld Y (2007) Anti-vitamin D, vitamin D in SLE: preliminary results. Ann N Y Acad Sci 1109:550–557PubMedCrossRef

64.

Bogaczewicz J, Sysa-Jedrzejowska A, Arkuszewska C, Zabek J, Kontny E, Wozniacka A (2010) Prevalence of autoantibodies directed against 1,25(OH)2D3 in patients with systemic lupus erythematosus. Pol Merkur Lekarski 28(164):103–107PubMed

65.

Al-Janadi M, Al-Balla S, Al-Dalaan A, Raziuddin S (1993) Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 13(1):58–67PubMedCrossRef

66.

Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240(4854):889–895PubMedCrossRef

67.

Ozaki Y, Nomura S, Nagahama M, Yoshimura C, Kagawa H, Fukuhara S (2000) Vitamin-D receptor genotype and renal disorder in Japanese patients with systemic lupus erythematosus. Nephron 85(1):86–91PubMedCrossRef

68.

Huang CM, Wu MC, Wu JY, Tsai FJ (2002) Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus 11(1):31–34PubMedCrossRef

69.

Sakulpipatsin W, Verasertniyom O, Nantiruj K, Totemchokchyakarn K, Lertsrisatit P, Janwityanujit S (2006) Vitamin D receptor gene BsmI polymorphisms in Thai patients with systemic lupus erythematosus. Arthritis Res Ther 8(2):R48PubMedCrossRef

70.

Abbasi M, Rezaieyazdi Z, Afshari JT, Hatef M, Sahebari M, Saadati N (2010) Lack of association of vitamin D receptor gene BsmI polymorphisms in patients with systemic lupus erythematosus. Rheumatol Int 30(11):1537–1539PubMedCrossRef

71.

Huang CM, Wu MC, Wu JY, Tsai FJ (2002) No association of vitamin D receptor gene start codon fok 1 polymorphisms in Chinese patients with systemic lupus erythematosus. J Rheumatol 29(6):1211–1213PubMed

72.

Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2011) Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 38:3643–3651PubMedCrossRef

73.

Monticielo OA, Brenol JC, Chies JA, Longo MG, Rucatti GG, Scalco R et al (2012) The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus. Lupus 21(1):43–52PubMedCrossRef

74.

Luo XY, Wu LJ, Yang MH, Liu NT, Liao T, Tang Z et al (2011) Relationship of vitamin D receptor gene Fok I polymorphism with systemic lupus erythematosus. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 27(8):901–905PubMed

75.

Luo XY, Yang MH, Wu FX, Wu LJ, Chen L, Tang Z et al (2011) Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population. Lupus 21(1):53–59PubMedCrossRef

Titel: Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus
verfasst von: Odirlei André Monticielo
Thaisa de Mattos Teixeira
José Artur Bogo Chies
João Carlos Tavares Brenol
Ricardo Machado Xavier
Publikationsdatum: 01.10.2012
Verlag: Springer-Verlag
Erschienen in: Clinical Rheumatology / Ausgabe 10/2012
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-012-2021-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2012

Changes in gene expression profiles of the hip joint ligament of patients with ankylosing spondylitis revealed by DNA chip

Autonomic neural control of the cardiovascular system in patients with Behçet’s disease in the absence of neurological involvement

Quantitative assessment of the “inexplicability” of fibromyalgia patients: a pilot study of the fibromyalgia narrative of “medically unexplained” pain

Genetic polymorphism of the growth arrest-specific 6 gene is associated with cutaneous vasculitis in Taiwanese patients with systemic lupus erythematosus

Association of FCRL4 polymorphisms on disease susceptibility and severity of ankylosing spondylitis in Chinese Han population